惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

爱范儿
爱范儿
WordPress大学
WordPress大学
C
Check Point Blog
GbyAI
GbyAI
U
Unit 42
Google DeepMind News
Google DeepMind News
B
Blog RSS Feed
Blog — PlanetScale
Blog — PlanetScale
J
Java Code Geeks
I
InfoQ
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Hugging Face - Blog
Hugging Face - Blog
Vercel News
Vercel News
博客园 - 【当耐特】
美团技术团队
小众软件
小众软件
S
SegmentFault 最新的问题
Jina AI
Jina AI
阮一峰的网络日志
阮一峰的网络日志
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
The Cloudflare Blog
Last Week in AI
Last Week in AI
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
V
Visual Studio Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
West Pharmaceutical Services, Inc. (WST) 46th Annual Will...
SA Transcripts · 2026-06-03 · via All Articles on Seeking Alpha

West Pharmaceutical Services, Inc. (WST) 46th Annual William Blair Growth Stock Conference June 2, 2026 5:00 PM EDT

Company Participants

Eric Green - Non-Independent Chair of the Board, President & CEO

Conference Call Participants

Matthew Larew - William Blair & Company L.L.C., Research Division

Presentation

Matthew Larew
William Blair & Company L.L.C., Research Division

Okay. Very good. Well, we're all set to get started here. I know we're towards the tail end of the day. So thanks, everyone, for sticking with us. Thanks for joining us for the West management presentation. My name is Matt Larew. I cover West here at William Blair. Pleased to be joined this morning by CEO -- afternoon -- by CEO, Eric Green; CFO, Bob McMahon; and John Sweeney from Investor Relations.

A couple of things to mention. First, the breakout session is in Maher upstairs, if you want to join us. Second, for a complete list of research disclosures or potential conflicts of interest, please visit our website at williamblair.com.

Finally, as many of you may know, Eric is retiring in August. And Eric, you've been a loyal attendee at our conference over the many years. So I just want to thank you for always taking time to come visit with us in Chicago and wish you the best in the next chapter of life. So again, very pleased to have West here, and I'll turn it over to Eric.

Eric Green
Non-Independent Chair of the Board, President & CEO

All right. Good afternoon, everybody. Thank you, Matt, for the introduction. And it's a pleasure being here. We had excellent one-on-one meetings all morning and afternoon and looking forward to the session but also Q&A following. Before we get started, I just want to -- I'm sure I can get this to work. There we go.